Business Description
Vistin Pharma ASA
ISIN : NO0010734122
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.25 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | 0.5 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 8.55 | |||||
Beneish M-Score | -3.21 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.8 | |||||
3-Year EPS without NRI Growth Rate | 38 | |||||
3-Year Book Growth Rate | 5.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 99.98 | |||||
9-Day RSI | 99.49 | |||||
14-Day RSI | 97.96 | |||||
6-1 Month Momentum % | -4.91 | |||||
12-1 Month Momentum % | 1.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.57 | |||||
Quick Ratio | 0.87 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 125.7 | |||||
Days Sales Outstanding | 47.2 | |||||
Days Payable | 42.7 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 5.21 | |||||
Dividend Payout Ratio | 0.81 | |||||
Forward Dividend Yield % | 7.29 | |||||
5-Year Yield-on-Cost % | 5.21 | |||||
Shareholder Yield % | 6 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 48.87 | |||||
Operating Margin % | 18.6 | |||||
Net Margin % | 15.6 | |||||
FCF Margin % | 4.76 | |||||
ROE % | 22.88 | |||||
ROA % | 17.28 | |||||
ROIC % | 17.72 | |||||
3-Year ROIIC % | 13.24 | |||||
ROC (Joel Greenblatt) % | 25.3 | |||||
ROCE % | 23.39 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 16.93 | |||||
PE Ratio without NRI | 16.93 | |||||
Shiller PE Ratio | 86.52 | |||||
Price-to-Owner-Earnings | 265.31 | |||||
PS Ratio | 2.63 | |||||
PB Ratio | 3.92 | |||||
Price-to-Tangible-Book | 3.92 | |||||
Price-to-Free-Cash-Flow | 55.32 | |||||
Price-to-Operating-Cash-Flow | 18.47 | |||||
EV-to-EBIT | 17.47 | |||||
EV-to-EBITDA | 13.92 | |||||
EV-to-Revenue | 2.9 | |||||
EV-to-FCF | 57.01 | |||||
Price-to-Graham-Number | 1.72 | |||||
Price-to-Net-Current-Asset-Value | 25.26 | |||||
Earnings Yield (Greenblatt) % | 5.72 | |||||
FCF Yield % | 1.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Vistin Pharma ASA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 437.687 | ||
EPS (TTM) (kr) | 1.536 | ||
Beta | 0 | ||
Volatility % | 16.48 | ||
14-Day RSI | 97.96 | ||
14-Day ATR (kr) | 0.101049 | ||
20-Day SMA (kr) | 22.65 | ||
12-1 Month Momentum % | 1.43 | ||
52-Week Range (kr) | 21 - 24.2 | ||
Shares Outstanding (Mil) | 44.34 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vistin Pharma ASA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vistin Pharma ASA Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Vistin Pharma ASA Frequently Asked Questions
What is Vistin Pharma ASA(OSTO:VISTINo)'s stock price today?
When is next earnings date of Vistin Pharma ASA(OSTO:VISTINo)?
Does Vistin Pharma ASA(OSTO:VISTINo) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |